2006

Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis LM. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. Journal of Clinical Oncology 2006; 24: 5711-5715.

Abrey LE, Panageas KS. Identifying and addressing barriers to the delivery of optimal therapy for primary central nervous system lymphoma in the broader community. Leukemia Lymphoma 2006; 47: 2449-2452.

Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, Chi DS, Barakat RR. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecologic Oncology 2006; 103: 714-718.

Akin O, Sala E, Moskowitz CS, Kuroiwa K, Ishill NM, Pucar D, Scardino PT, Hricak H. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006; 239: 784-792.

Allen PJ, D'Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, DeMatteo R, Fong Y, Blumgart LH, Brennan MF. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Annals of Surgery 2006; 244: 572-582.

Amar D, Goenka A, Zhang H, Park B, Thaler HT. Leukocytosis and increased risk of atrial fibrillation after general thoracic surgery. Annals of Thoracic Surgery 2006; 82: 1057-1061.

Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi D, Sabbatini P, Soslow RA. p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas. International Journal of Gynecological Cancer 2006; 16: 849-853.

Arber N, Eagle C, Spicak J, Racz I, Dite P, Hajer J, Zavoral M, Lechuga MJ, Gerletti P, Tang J, Rosenstein RB, Macdonald K, Bhadra P, Fowler R, Wittes J, Zauber AG, Solomon SD, Levin B. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006;355:885-95.

Arber N, Solomon S, Wittes J, Lechuga M, Gerletti P, MacDonald K, Eale C, Pfeffer M, McMurray J, Fowler R, Finn P, Zauber A, Ruschitzka F, Levin B. Cardiovascular outcomes from a long-term randomized colorectal adenoma chemoprevention trial of a once-daily dose of celecoxib. Gastroenterology 2006: 130 S A: 57 381

Are C, Gonen M, D'Angelica M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Differential diagnosis of proximal biliary obstruction. Surgery 2006; 140: 756-763.

Bach PB, McClellan MB. The first months of the prescription-drug benefit-a CMS update. New England Journal of Medicine 2006; 354: 2312-2314.

Ballas LK, Elkin EB, Schrag D, Minsky BD, Bach PB. Radiation therapy facilities in the United States. International Journal of Radiation Oncology, Biology, Physics 2006; 66: 1204-1211.

Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): Impact of adequate staging on outcome. Annals of Surgical Oncology 2006; [Epub ahead of print]

Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, Scher HI, Schrag D. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncology 2006; 7: 903-909.

Basch EM, Artz D, Speakman J, Iasonos A, Shannon K, Lin K, Pun C, Yong H, Barz A, McCabe M, Schrag D. Design, implementation, and evaluation of a web portal for patient symptom monitoring. Journal of the American Medical Information Association 2006; 14: (in press).

Begg CB, Brawley O, Califf RM, Demets DL, Ellenberg SS, Kaplan RS. Marketing drugs too early in testing. Science 2006; 312: 195.

Begg CB, Eng KH, Hummer AJ. Statistical tests for clonality. Biometrics 2006 (in press).

Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Berwick M; GEM Study Group. A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. International Journal of Epidemiology 2006; 35: 756-764.

Begg CB. Response to "Case-control and case-only designs with genotype and family history data: estimating relative risk, residual familial aggregation, and cumulative risk" by Chatterjee et al. Biometrics 2006; (in press).

Bekelman JE, Rosenzweig KE, Bach PB, Schrag D. Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 2006; 66: 492-499.

Ben-Porat L, Panageas KS, Hanlon C, Patel A, Halpern A, Houghton AN, Coit D. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on cancer staging system for melanoma. Cancer 2006; 106: 163-171.

Berger AD, Satagopan J, Lee P, Taneja SS, Osman I. Differences in clinicopathologic features of prostate cancer between black and white patients treated in the 1990s and 2000s. Urology 2006; 67: 120-124.

Berman E, Nicolaides M, Maki RG, Fleisher M, Chanel S, Scheu K, Wilson BA, Heller G, Sauter NP. Altered bone and mineral metabolism in patients receiving imatinib mesylate. New England Journal of Medicine 2006; 354: 2006-2013.

Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry. Human Mutations 2006; 27: 1122-1128.

Bernstein JL, Teraoka SN, John EM, Andrulis IL, Knight JA, Lapinski R, Olson ER, Wolitzer AL, Seminara D, Whittemore AS, Concannon P. The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry. Cancer Epidemiology, Biomarkers and Prevention 2006; 15: 348-352.

Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, Hess TM, Woloj GM, Boisserie F, Anderson WF, Viner JL, Bagheri D, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Gordon GB, Hawk ET; APC Study Investigators. Celecoxib for the prevention of sporadic colorectal adenomas. New England Journal of Medicine 2006; 355: 873-884.

Berwick M, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Wilcox H, Begg CB; GEM Study Group. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiology, Biomarkers and Prevention 2006; 15: 1520-1525.

Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA. Missed opportunities: racial disparities in adjuvant breast cancer treatment. Journal of Clinical Oncology 2006; 24: 1357-1362.

Boyle JO, Lillico AJ, Kuriakose MA. Feasibility of international chemoprevention trials. New York Presbyterian Hospital Cancer Prevention Newsletter, Issue 8, Fall 2006.

Brady MS, Akhurst T, Spanknebel K, Hilton S, Gonen M, Patel A, Larson S. Utility of preoperative [(18)]f fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients. Annals of Surgical Oncology 2006; 13: 525-532.

Brendler T, Gruenwald J, Ulbricht C, Basch E. Natural Standard Research Collaboration. Devil's Claw (Harpagophytum procumbens DC): an evidence-based systematic review by the Natural Standard Research Collaboration. Journal of Herbal Pharmacotherapy 2006; 6: 89-126.

Brenner B, Shah MA, Karpeh MS, Gonen M, Brennan MF, Coit DG, Klimstra DS, Tang LH, Kelsen DP. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Annals of Oncology 2006; 17: 1404-1411.

Budak-Alpdogan T, Przybylowski M, Gonen M, Sadelain M, Bertino J, Riviere I. Functional assessment of the engraftment potential of gammaretrovirus-modified CD34+ cells, using a short serum-free transduction protocol. Human Gene Therapy 2006; 17: 780-794.

Capanu M, Jones GA, Randles RH. Testing for preference using a sum of Wilcoxon signed rank statistics. Computational Statistics and Data Analysis 2006; 51: 793-796

Carver BS, Bianco FJ, Shavegan B, Vickers AJ, Motzer RJ, Bosl GJ, Sheinfeld J. Predicting teratoma in the retroperitoneum for men undergoing post-chemotherapy retroperitoneal lymph node dissection. Journal of Urology 2006; 176: 100-104.

Chadalavada RS, Korkola JE, Houldsworth J, Olshen AB, Bosl GJ, Studer L, Chaganti RS. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem Cells 2006; [Epub ahead of print]

Chen W, Houldsworth J, Olshen AB, Nanjangud G, Chaganti S, Venkatraman ES, Halaas J, Teruya-Feldstein J, Zelenetz AD, Chaganti RS. Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood 2006; 107: 2477-2485.

Cheung IY, Vickers AJ, Cheung NK. Sialyltransferase STX (ST8SiaII): a novel molecular marker of neuroblastoma. International Journal of Cancer 2006; 119: 152-156.

Cheung NKV, Vickers AJ, Gorlick R. FcγRIIa polymorphism correlates with treatment outcome of metatastic neuroblastoma following immunotherapy using murine IgG3 anti-GD2 antibody and GM-CSF. Journal of Clinical Oncology 2006; 24: 2885-2890.

Chi DS, McCaughty K, Diaz JP, Huh J, Schwabenbauer S, Hummer AJ, Venkatraman ES, Aghajanian C, Sonoda Y, Abu-Rustum NR, Barakat RR. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 2006; 106: 1933-1939.

Cronin KA, Gail MH, Zou Z, Bach PB, Virtamo J, Albanes D. Validation of a model of lung cancer risk prediction among smokers. Journal of the National Cancer Institute 2006; 98: 637-640.

Cucchiaro G, Farrar, JT, Guite JW, Li Y. What postoperative outcomes matter to pediatric ptients? Anesthesia and Analgesia 2006; (in press).

D'Angelica M, Kornprat P, Gonen M, Chung KY, Jarnagin WR, Dematteo RP, Fong Y, Kemeny N, Blumgart LH, Saltz LB. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: A matched case-control study. Annals of Surgical Oncology 2006; [Epub ahead of print].

D'Angelica M, Maddineni S, Fong Y, Martin RC, Cohen MS, Ben-Porat L, Gonen M, DeMatteo RP, Blumgart LH, Jarnagin WR. Optimal abdominal incision for partial hepatectomy: increased late complications with Mercedes-type incisions compared to extended right subcostal incisions. World Journal of Surgery 2006; 30: 410-418.

Dash A, Galsky MD, Vickers AJ, Serio AM, Koppie TM, Dalbagni G, Bochner BH. Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder. Cancer. 2006; 107: 506-513.

Dash A, Vickers AJ, Schacter L, Bach A, Snyder M, Russo P. Elective partial versus elective radical nephrectomy for clear cell renal cell carcinoma 4-7 cm in size. BJU International 2006; 97: 939-945.

Davis JA, McBride MG, Chrisant MRK, Patil SM, Hanna BD, Paridon SM. Longitudinal assessment of cardiovascular exercise performance after pediatric heart transplantation. The Journal of Heart and Lung Transplantation 2006; 25: 626-633.

DiBlasio CJ, Masterson TA, Fearn PA, Seo HS, Rabbani F, Vickers AJ, Eastham JA, Scardino PT. The association between total and positive lymph node counts, disease progression in clinically localized prostate cancer. Journal of Urology 2006; 175: 1320-1324.

Diefenbach CS, Shah Z, Iasonos A, Barakat RR, Levine DA, Aghajanian C, Sabbatini P, Hensley ML, Konner J, Tew W, Spriggs D, Fleisher M, Thaler H, Dupont J. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer. Gynecologic Oncology 2007;104:435-42.

Diefenbach CS, Soslow RA, Iasonos A, Linkov I, Hedvat C, Bonham L, Singer J, Barakat RR, Aghajanian C, Dupont J. Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival. Cancer 2006; 107: 1511-1519.

Donohue JF, Bianco FJ, Kuroiwa K, Vickers AJ, Wheeler TM, Scardino PT, Reuter V, Eastham JA. Poorly differentiated prostate cancer treated by radical prostatectomy: Long-term outcome and incidence of downgrading. Journal of Urology 2006; 176: 991-995.

Douglas DA, Zhong H, Ro JY, Oddoux C, Berger AD, Pincus MR, Satagopan JM, Gerald WL, Scher HI, Lee P, Osman I. Novel mutations of epidermal growth factor receptor in localized prostate cancer. Frontiers in Bioscience 2006; 11: 2518-2525.

Dupont J, Aghajanian C, Andrea G, Lovegren M, Chuai S, Venkatraman E, Hensley M, Anderson S, Spriggs D, Sabbatini P. Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important? International Journal of Gynecology Cancer 2006; 16 Suppl 1:68-73.

Elkin EB, Hurria A, Mitra N, Schrag D, Panageas KS. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. Journal of Clinical Oncology 2006; 24: 2757-2764.

Elkin EB, Vickers AJ, Kattan MW. Primer: using decision analysis to improve clinical decision making in urology. National Clinical Practice in Urology 2006; 3: 439-448.

Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock G, Brock JW, Bush D, Hoover RN, Rothman N. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin lymphoma: a report from three cohorts. Cancer Research 2006; (in press).

Engel LS, Lan Q, Rothman N. Polychlorinated biphenyls and non-Hodgkin lymphoma. Cancer Epidemiology, Biomarkers, and Prevention 2006; (in press).

Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robison LL, Sklar CA. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. Journal of Clinical Endocrinology and Metabolism 2006; 91: 3494-3498.

Ezzo JM, Richardson MA, Vickers AJ, Allen C, Dibble SL, Issell BF, Lao L, Pearl M, Ramirez G, Roscoe JA, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. Cochrand Database of Systematic Reviews 2006; Apr 19: (2): CD002285.

Feltquate D, Nordquist L, Eicher C, Morris M, Smaletz O, Slovin S, Curley T, Wilton A, Fleisher M, Heller G, Scher HI. Rapid androgen cycling as treatment for patients with prostate cancer. Clinical Cancer Research 2006; 12: 7414-7421.

Ferguson SE, Olshen AB, Levine DA, Viale A, Barakat RR, Boyd J. Molecular profiling of endometrial cancers from African-American and Caucasian women. Gynecologic Oncology 2006; 101: 209-213.

Fleming MT, Morris MJ, Heller G, Scher HI. Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials. National Clinical Practice in Oncology 2006; 3: 658-667. Review.

Flores RM, Akhurst T, Gonen M, Zakowski M, Dycoco J, Larson SM, Rusch VW. Positron emission tomography predicts survival in malignant pleural mesothelioma. Journal of Thoracic Cardiovascular Surgery 2006; 132: 763-768.

Fong Y, Wagman L, Gonen M, Crawford J, Reed W, Swanson R, Pan C, Ritchey J, Stewart A, Choti M. Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Annals of Surgery 2006; 243: 767-771; discussion 771-774.

Fornier MN, Seidman AD, Lake D, D'Andrea G, Bromberg J, Robson M, VanPoznak C, Panageas KS, Atienza M, Norton L, Hudis C. Increased dose-density is feasible: A pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10 or 11 day intervals with filgrastim support in women with breast cancer, Clinical Cancer Research 2006; (in press).

Fridlyand J, Snijders AM, Ylstra B, Li H, Olshen A, Segraves R, Dairkee S, Tokuyasu T, Ljung BM, Jain AN, McLennan J, Ziegler J, Chin K, Devries S, Feiler H, Gray JW, Waldman F, Pinkel D, Albertson DG. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 2006; 6: 96.

Fury MG, Zahalsky A, Wong R, Venkatraman E, Lis E, Hann L, Aliff T, Gerald W, Fleisher M, Pfister DG. A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers. Investigational New Drugs 2006 (in press).

Galsky MD, Mironov S, Iasonos A, Scattergood J, Boyle MG, Bajorin DF. Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma. Investigational New Drugs 2006; [Epub ahead of print]

Gerecitano J, Goy A, Wright J, MacGregor-Cortelli B, Neylon E, Gonen M, Esseltine D, Boral A, Schenkein D, Busam K, Teruya-Feldstein J, Sachs D, O'Connor OA. Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response? British Journal of Haematology 2006; 134: 391-398.

Gilheeney SW, Lyden DC, Sgouros S, Antunes N, Gerald W, Kramer K, Lis E, Meyers P, Rosen N, Thaler HT, Trippett T, Wexler L, Dunkel IJ. A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies. Pediatric Blood Cancer 2006; [Epub ahead of print]

Gold JS, van der Zwan SM, Gönen M, Maki RG, Singer S, Brennan MF, Antonescu CR, Dematteo RP. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors. Annals of Surgical Oncology 2006; [Epub ahead of print]

Goldfrank D, Chuai S, Bernstein JL, Ramon Y Cajal T, Lee JB, Alonso MC, Diez O, Baiget M, Kauff ND, Offit K, Robson M. Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. Cancer Epidemiology, Biomarkers and Prevention 2006; 15: 2311-2313.

Gollub MJ, Yoon S, Smith LM, Moskowitz CS. Does the CT whirl sign really predict small bowel volvulus? Experience in an oncologic population. Journal of Computed Assisted Tomography 2006; 30: 25-32.

Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D'Angelica M, DeMatteo RP, Schwartz L, Blumgart LH, Jarnagin WR. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Annals of Surgery 2006; 244: 260-264.

Halpern NA, Pastores SM, Thaler HT, Greenstein RJ. Changes in critical care beds and occupancy in the United States 1985-2000: Differences attributable to hospital size. Critical Care Medicine 2006; 34: 2105-2112.

Hanley JA, Dendukuri N, Begg CB. Response to "Multiple imputation for correcting verification bias" (letter). Statistics in Medicine 2006; (in press).

Hay J, Burkhalter J, Ostroff J, Li Y, Quiles Z, Moadel A. Changes in cancer-related risk perception and smoking across time in newly-diagnosed cancer patients. Journal of Behavioral Medicine 2006; (in press).

Heller G. Power calculations for preclinical studies using a K-sample rank test and the Lehmann alternative hypothesis. Statistics in Medicine 2006; 25: 2543-2553.

Hensley ML, Correa DD, Thaler H, Wilton A, Venkatraman E, Sabbatini P, Chi DS, Dupont J, Spriggs D, Aghajanian C. Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning. Gynecologic Oncology 2006; 102: 270-277.

Hormigo A, Gu B, Karimi S, Riedel E, Panageas KS, Edgar MA, Tanwar MK, Rao JS, Fleisher M, DeAngelis LM, Holland EC. YKL-40 and matrix etalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. Clinical Cancer Research 2006; 12: 5698-5704.

Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj G, Scardino PT, Russo P. Chronic kidney disease following nephrectomy in patients with renal cortical tumors. Lancet Oncology 2006; 7: 735-740.

Hurria A, Fleming MT, Baker SD, Kelly WK, Cutchall K, Panageas K, Caravelli J, Yeung H, Kris MG, Gomez J, Miller VA, D'Andrea G, Scher HI, Norton L, Hudis C. Pharmacokinetics and toxicity of weekly docetaxel in older patients. Clinical Cancer Research 2006; 12 (20 Pt 1): 6100-6105.

Hurria A, Hurria A, Zuckerman E, Panageas KS, Fornier M, D'Andrea G, Dang C, Moasser M, Robson M, Seidman A, Currie V, VanPoznak C, Theodoulou M, Lachs MS, Hudis C. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. Journal of the American Geriatrics Society 2006: 54: 1119-1124.

Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas KS, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Hurria A, Holland J. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. Journal of the American Geriatric Society 2006; 54: 925-931.

Hwu WJ, Panageas KS, Menell JH, Lamb LA, Aird S, Krown SE, Williams LJ, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma. Cancer 2006; 106: 2445-2451.

Indurkhya A, Mitra N, Schrag D. Using propensity scores to estimate the cost-effectiveness of medical therapies. Statistics in Medicine 2006; 25: 1561-1576.

Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam A, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter DJ, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, O'Brien TR, Petersen G, Riboli E, Salanti G, Seminara D, Smeeth L, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Khoury MJ; Human Genome Epidemiology Network and the Network of Investigator Networks. A road map for efficient and reliable human genome epidemiology. Nature Genetics 2006; 38: 3-5.

Jarnagin WR, Klimstra DS, Hezel M, Gonen M, Fong Y, Roggin K, Cymes K, DeMatteo RP, D'Angelica M, Blumgart LH, Singh B. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. Journal of Clinical Oncology 2006; 24: 1152-1160.

Jarnagin WR, Zager JS, Hezel M, Stanziale SF, Adusumilli PS, Gonen M, Ebright MI, Culliford A, Gusani NJ, Fong Y. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy. Cancer Gene Therapy 2006; 13: 326-334.

Kamel F, Engel LS, Gladen BC, Hoppin JA, Alavanja MC, Sandler DP. Pesticide use and neurologic symptoms in the Agricultural Health Study. Human Experimental Toxicology 2006; (in press).

Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Busam K, From L, Mujumdar U, Wilcox H, Begg CB, Berwick M. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Research 2006; 66: 9330-9337.

Khokhar A, Vickers AJ, Moore MS, Mironov S, Stover DE, Feinstein MB. Significance of non-calcified pulmonary nodules among patients with extra-pulmonary cancers. Thorax 2006; 61: 331-336.

Kissane DW, McKenzie M, Bloch S, Moskowitz C, McKenzie DP, and O'Neill I. Family focused grief therapy: a randomized controlled trial in palliative care and bereavement. American Journal of Psychiatry 2006; 163: 1208-1218.

Kligler B, Ulbricht C, Basch E, Kirkwood CD, Abrams TR, Miranda M, Singh Khalsa KP, Giles M, Boon H, Woods J. Andrographis paniculata for the treatment of upper respiratory infection: a systematic review by the natural standard research collaboration. Explore (NY) 2006; 2: 25-29. Review.

Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH. Standardization of pelvic lymphadenectomy performed at radical cystectomy: Can we establish a minimum number of lymph nodes that should be removed? Cancer 2006; 107: 2368-2374.

Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE, Bosl GJ, Chaganti RS. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Research 2006; 66: 820-827.

Kornprat P, Jarnagin WR, Gonen M, Dematteo RP, Fong Y, Blumgart LH, D'Angelica M. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Annals of Surgical Oncology 2006; [Epub ahead of print].

Kricker A, Armstrong BK, Goumas C, Litchfield M, Begg CB, Hummer AJ, Marrett LD, Theis B, Millikan RC, Thomas N, Anton-Culver H, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Mujumdar U, Zanetti R, Berwick M. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes and Control 2006; (in press)

Lamanna N, Kalaycio M, Maslak P, Jurcic JG, Heaney M, Brentjens R, Zelenetz AD, Horgan D, Gencarelli A, Panageas KS, Scheinberg DA, Weiss MA. Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia. Journal of Clinical Oncology 2006; 24: 1575-1581.

Langholz B, Bernstein JL, Bernstein L, Olsen JH, Borresen-Dale AL, Rosenstein BS, Gatti RA; The WECARE Study Collaborative Group; Concannon P. On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer. International Journal of Cancer 2006; 119: 724-725.

Largent JA, Capanu M, Bernstein L, Langholz, B, Mellemkjaer L, Malone KE, Begg CB, Haile RW, Lynch CF, Anton-Culver H, Wolitzer A, Bernstein JL. Reproductive history and risk of second primary breast cancer: the WECARE Study. Cancer Epidemiology Biomarkers and Prevention 2006; (in press).

Lassman AB, Abrey LE, Shah GD, Panageas KS, Begemann M, Malkin MG, Raizer JJ. Systemic high-dose intravenous methotrexate for central nervous system metastases. Journal of Neurooncology 2006; 78: 255-260. Erratum in: Journal of Neurooncology 2006; 78: 261. Shah, Gaurav G [corrected to Shah, Gaurav D].

Lee NY, de Arruda FF, Puri DR, Wolden SL, Narayana A, Mechalakos J, Venkatraman ES, Kraus D, Shaha A, Shah JP, Pfister DG, Zelefsky MJ. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics 2006; 66: 966-974.

Leiser AL, Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi DS, Soslow RA. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecologic Oncology 2006; 101: 86-91.

Levin TT, Riskind JH, Li Y. Looming Cognitive Style in a Cancer Cohort. General Hospital Psychiatry 2006; (in press).

Li Y. Using the open-source statistical language R to analyze the Rasch model. Behavioral Research Methods, Instruments, & Computers 2006; 38: 532-541.

Liau KH, Ruo L, Shia J, Padela A, Gönen M, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, DeMatteo RP. Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma. Cancer 2006; 104: 1945-1955.

Loganathan RS, Stover DE, Shi W, Venkatraman E. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest 2006; 129: 1305-1312.

Lopez-Rios F, Chuai S, Flores R, Shimizu S, Ohno T, Wakahara K, Illei PB, Hussain S, Krug L, Zakowski MF, Rusch V, Olshen AB, Ladanyi M. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Research 2006; 66: 2970-2979.

Lyman S, Sherman S, Carter TI, Bach PB, Mandl LA, Marx RG. Prevalence and risk factors for symptomatic thromboembolic events after shoulder arthroplasty. Clinical Orthopaedics and Related Research 2006; 448:152-156.

Maluf FC, Cordon-Cardo C, Verbel DA, Satagopan JM, Boyle MG, Herr H, Bajorin DF. Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment. Annals of Oncology 2006; 17: 1677-1686.

McCreath WA, Eisenhauer EL, Abu-Rustum NR, Venkatraman ES, Caceres A, Bier R, Huh J, Cho J, Barakat RR, Chi DS. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma. Gynecologic Oncology 2006; 102: 8-14.

McQuellon RP, Thaler HT, Cella D, Moore DH. Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study. Gynecologic Oncology 2006; 101: 296-304.

Millikan RC, Hummer A, Begg C, Player J, René de Cotret A, Winkel S, Mohrenweiser H, Thomas N, Armstrong B, Kricker A, Marrett LD, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck T, Busam K, From L, Mujumdar U, Berwick M. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the genes environment and melanoma study. Carcinogenesis 2006; 27: 3610-3618.

Milton DT, Azzoli CG, Heelan RT, Venkatraman E, Gomez JE, Kris MG, Krug LM,Pao W, Rizvi NA, Dunne M, Miller VA. A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer. Cancer 2006; 107: 1034-1041.

Moskowitz CS, Pepe MS. Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs. Clinical Trials 2006; 3: 272-279.

Mourton SM, Chi DS, Sonoda Y, Alektiar KM, Venkatraman ES, Barakat RR, Abu-Rustum NR. Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies. Gynecologic Oncology 2006; 100: 533-536.

Mullerad M, Eisenberg DP, Akhurst TJ, Adusumilli PS, Riedl CC, Bhargava A, Gönen M, Finn R, Scardino PT, Fong Y. Use of positron emission tomography to target prostate cancer gene therapy by oncolytic herpes simplex virus. Molecular Imaging and Biology 2006; 8: 30-35.

Olson SH, Bandera EV, Orlow I. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: A HuGE Review. American Journal of Epidemiology 2006; [Epub ahead of print]

Orlow I, Begg CB, Cotignola J, Pampa R, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M for GEM Study Group. CDKN24 Germline Mutations in Individuals with Cutaneous Malignant Melanoma. Journal of Investigative Dermatology 2007; (in press).

Panageas KS, Ben-Porat L, Dickler MN, Chapman PB, Schrag D. When you look matters: The effect of assessment schedule on progression free survival, J Natl Can Inst, in press.

Panageas KS, Schrag D, Localio AR, Venkatraman ES, Begg CB. Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size. Statistics in Medicine 2006; (in press).

Patil SM, Shope JT, Raghunathan TE, Bingham CR. The role of personality characteristics in young adult driving. Traffic Injury Prevention 2006; 7: 328-334.

Perales MA, Diab A, Cohen AD, Huggins DW, Guevara-Patino JA, Hubbard VM, Engelhorn ME, Kochman AA, Eng JM, Mortazavi F, Alpdogan O, Terwey TH, Heller G, Wolchok JD, Houghton AN, van den Brink MR. DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation. Journal of Immunology 2006; 177: 4159-4167.

Pettus JA, Eggener SE, Shabsigh A, Yanke B, Snyder ME, Serio A, Vickers A, Russo P, Donat SM. Perioperative clinical thromboembolic events after radical or partial nephrectomy. Urology 2006; 68: 988-992.

Pham D, Kris MG, Riely GJ, Sarkaria IS, McDonough T, Chuai S, Venkatraman ES, Miller VA, Ladanyi M, Pao W, Wilson RK, Singh B, Rusch VW. Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung denocarcinomas. Journal of Clinical Oncology 2006; 24: 1700-1704.

Port ER, Yeung H, Gonen M, Liberman L, Caravelli J, Borgen P, Larson S. 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma. Annals of Surgical Oncology 2006; 13: 677-684.

Pryma DA, Schoder H, Gonen M, Robbins RJ, Larson SM, Yeung HW. Diagnostic accuracy and prognostic value of 18F-FDG PET in hurthle cell thyroid cancer patients. Journal of Nuclear Medicine 2006; 47: 1260-1266.

Qin LX, Beyer R, Hudson N, Linford N, Morris D, Kerr KF. Validation of data transformation methods for oligonucleotide arrays with qRT-PCR measurements. BMC Bioinformatics 2006; 7: 23.

Qin LX, Self SG. The clustering of regression models method with applications to gene expression data. Biometrics 2006; 62: 526-533.

Raj GV, Bochner BH, Vickers AJ, Teper E, Lin O, Donat SM, Herr H, Dalbagni G. Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract. Journal of Urology 2006; 175: 2038-2041.

Raj GV, Iasonos A, Herr H, Donat SM. Formulas calculating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer. Journal of Clinical Oncology 2006; 24: 3095-3100.

Raj GV, Tal R, Vickers AJ, Bochner BH, Serio A, Donat SM, Herr H, Olgac S, Dalbagni G. Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer. Cancer. 2006; 107: 2167-2172.

Raj GV, Bochner BH, Serio AM, Vickers AJ, Donat SM, Herr H, Lin O, Dalbagni G. Natural history of patients with positive urinary cytologies after radical cystectomy. Journal of Urology 2006; 176: 2000-2005.

Reid ME, Duffield-Lillico AJ, Sunga A, Alberts DS, Marshall JR. Selenium supplementation and colorectal adenomas: an analysis of the Nutritional Prevention of Cancer Trial. International Journal of Cancer 2006; 118: 1777-1781.

Riely GJ, Pao W, Pham D, Li AR, Rizvi N, Venkatraman ES, Zakowski MF, Kris MG, Ladanyi M, Miller VA. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Clin Cancer Research 2006; 12(3 Pt 1):839-844.

Rizk N, Downey RJ, Akhurst T, Gonen M, Bains MS, Larson S, Rusch V. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Annals of Thoracic Surgery 2006; 81: 1076-1081.

Robbins RJ, Wan Q, Grewal RK, Reibke R, Gönen M, Strauss HW, Tuttle RM, Drucker W, Larson SM. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. Journal of Clinical Endocrinology and Metabolism 2006; 91: 498-505.

Sabbatini P, Dupont J, Aghajanian C, Derosa F, Poynor E, Anderson S, Hensley M, Livingston P, Iasonos A, Spriggs D, McGuire W, Reinartz S, Schneider S, Grande C, Lele S, Rodabaugh K, Kepner J, Ferrone S, Odunsi K. Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer. Clinical Cancer Research 2006; 12: 5503-5510.

Sala E, Akin O, Moskowitz CS, Eisenberg HF, Kuroiwa K, Ishill NM, Rajashanker B, Scardino PT, Hricak H. Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. Radiology 2006; 238: 929-937.

Sala E, Eberhardt SC, Akin O, Moskowitz CS, Onyebuchi CN, Kuroiwa K, Ishill N, Zelefsky MJ, Eastham JA, Hricak H. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. Radiology 2006; 238: 176-183.

Sandhu JS, Vickers AJ, Bochner B, Donat SM, Herr HW, Dalbagni G. Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer. BJU International 2006; 98: 59-62.

Santiago JF, Gonen M, Yeung H, Macapinlac H, Larson S. A retrospective analysis of the impact of 18F-FDG PET scans on clinical management of 133 breast cancer patients. Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2006; 50: 61-67.

Schoder H, Carlson DL, Kraus DH, Stambuk HE, Gonen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM, Wong RJ. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. Journal of Nuclear Medicine 2006; 47: 755-762.

Schrag D, Earle C, Xu F, Panageas KS, Yabroff KR, Bristow RE, Trimble EL, Warren JL. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. Journal of the National Cancer Institute 2006; 98: 163-171.

Schrag D, Xu F, Hanger M, Elkin E, Bickell NA, Bach PB. Fragmentation of care for frequently hospitalized urban residents. Medical Care 2006; 44: 560-567.

Secin FP, Bianco FJ, Vickers AJ, Fearn P, Scardino PT, Eastham JA. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy. Cancer 2006; 106: 2369-2375.

Sen S, Satagopan JM, Broman K, Churchill GA. R/qtlDesign: Inbred line cross experimental design. Mammalian Genome 2006 (in press).

Shah MA, Ramanathan RK, Ilson DH, Levnor A, D'Adamo D, O'Reilly E, Tse A, Trocola R, Schwartz L, Capanu M, Schwartz GK, Kelsen DP. A multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma. Journal of Clinical Oncology 2006; 24: 5201-5206.

Shike M, Genao A, Zauber A, Burke M, Schattner M, Grant W, Cuyjet V, Samuel S, Marsh F, Russo L, Rodriguez R, Freeman H. A prospective study of community screening colonoscopy in African American Women (AAW) and Latino women (LW): Barriers, compliance, results and satisfaction. Gastroenterology 2006: 130; S A:187 S1255.

Solomon SD, Pfeffer MA, McMurray JJV, Fowler R, Finn P, Levin B, Eagle C, Hawk E, Lechuga M, Zauber AG, Bertagnolli M, Arber N, Wittes J. Effect of celecoxib on cardiovascular events and blood pressure in two trials for prevention of colorectal adenoma. Circulation 2006,114:1028-1035.

Steenhoff AP, Shah SS, Ratner AJ, Patil SM, McGowan KL. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clinical Infectious Diseases 2006; 42: 907-914.

Steenhoff AP, Shah SS, Ratner AJ, Patil SM, McGowan KL. Reply to Robertson et al. Clinical Infectious Diseases. Clinical Infectious Diseases 2006; 43: 544-545.

Steinberg AG, Bain L, Ewing R, Li Y. Meeting the Public's Health Information Needs: A plain language website outreach project: to reaching underserved parents of deaf children. Health Communication 2006; (in press).

Steuber T, Vickers AJ, Haese A, Becker C, Pettersson K, Chun FK-H, Kattan MW, Eastham JA, Scardino PT, Huland H, Lilja H. Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 and free prostate-specific antigen (PSA) in men with moderate PSA-elevation in serum. International Journal of Cancer 2006; 118: 1234-1240.

Stiles BM, Adusumilli PS, Stanziale SF, Eisenberg DP, Bhargava A, Kim TH, Chan MK, Huq R, Gonen M, Fong Y. Estrogen enhances the efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor-positive breast cancer. International Journal of Oncology 2006; 28: 1429-1439.

Su YB, Vickers AJ, Zelefsky MJ, Kraus DH, Shaha AR, Shah JP, Serio AM, Barrison LB, Bosl GJ, Pfister DG. Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor (G-CSF) during post-operative radiotherapy for squamous head and neck cancer. Cancer Journal 2006; 12: 182-188.

Taylor RA, Patel A, Panageas KS, Busam KJ, Brady MS. Tumor infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma, J Clin Onc, in press.

Toner LE, Vrhovac R, Smith EA, Gardner J, Heaney M, Gönen M, Teruya-Feldstein J, Sirotnak F, O'Connor OA. The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma. Clinical Cancer Research 2006; 12: (3 Pt 1):924-932.

Touijer K, Kuroiwa K, Vickers AJ, Reuter VE, Guillonneau B. Impact of a multidisciplinary continuous quality improvement program on the positive surgical margin rate after laparoscopic radical prostatectomy. European Urology 2006; 49: 853-858.

Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DeMichele A, Figg WD, Gospodarowicz MK, Hall EJ, Hisada M, Inskip P, Kleinerman R, Little JB, Malkin D, Ng AK, Offit K, Pui CH, Robison LL, Rothman N, Shields PG, Strong L, Taniguchi T, Tucker MA, Greene MH. Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. Journal of the National Cancer Institute 2006; 98: 15-25.

Tuma R, Almyroudis N, Sohn S, Panageas K, Rice R, Galinkin D, Blain M, Montefusco M, Pamer E, Nimer S, Kewalramani T. The serum IL-12:IL-6 ratio reliably distinguishes infectious from non-infectious causes of fever during autologous stem cell transplantation. Cytotherapy 2006; 8: 327-334.

Ulbricht C, Basch E, Bent S, Boon H, Corrado M, Foppa I, Hashmi S, Hammerness P, Kingsbury E, Smith M, Szapary P, Vora M, Weissner W. Evidence-based systematic review of saw palmetto by the Natural Standard Research Collaboration. Journal of Society of Intergrative Oncology 2006; 4: 170-186.

Ulbricht C, Basch E, Weissner W, Hackman D. An evidence-based systematic review of herb and supplement interactions by the Natural Standard Research Collaboration. Expert Opinion on Drug Safety 2006; 5: 719-728. Review.

Van Poznak C, Cross SS, Saggese M, Hudis C, Panageas KS, Norton L, Coleman RE, Holen I. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours. Journal of Clinical Pathology 2006; 59: 56-63.

Venkatraman ES, Olshen AB. A faster CBS algorithm for the analysis of array CGH data. Biostatistics 2006; (in press).

Vickers AJ, Bianco FJ, Boorjian S, Scardino P, Eastham JA. Does delay between diagnosis and radical prostatectomy increase the risk of cancer recurrence? Cancer 2006; 106: 576-580.

Vickers AJ, Kramer BS, Baker SG. Selecting patients for randomized trials: a systematic approach based on risk group. Trials 2006; 7: 30.

Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Medical Decision Making 2006; 26: 565-574.

Vickers AJ, Kuo J, Cassileth BR. Unconventional anticancer agents: a systematic review of clinical trials. Journal of Clinical Oncology 2006; 24: 136-140.

Vickers AJ, Rusch VW, Malhotra VT, Downey RJ, Cassileth BR. Acupuncture is a feasible treatment for post-thoracotomy pain: Results of a prospective clinical trial. BMC Anaesthesia 2006; 6: 5.

Vickers AJ. How to design a Phase I trial of an anticancer botanical. Journal of the Society for Integrative Oncology 2006; 4: 46-51.

Vickers AJ. How to measure quality of life in integrative oncology research. Journal of the Society for Integrative Oncology 2006; 4: 100-103.

Vickers AJ. How to randomize. Journal of the Society for Integrative Oncology 2006; 4: 194-198.

Vickers AJ. Multiple assessment in quality of life trials: how many questionnaires? How often should they be given? Journal of the Society for Integrative Oncology 2006; 4: 135-139.

Vickers AJ. Whose data set is it anyway? Sharing raw data from randomized trials. Trials 2006: 7: 15.

Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst P. Differential exoprotease activities confer tumor-specific serum peptidome patterns. Journal of Clinical Investigation 2006; 116: 271-284.

Vogelaar I, van Ballegooijen M, Schrag D, Boer R, Winawer SJ, Habbema JD, Zauber AG. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer 2006; 107: 1624-1633.

Weyant MJ, Bains MS, Venkatraman E, Downey RJ, Park BJ, Flores RM, Rizk N, Rusch VW. Results of chest wall resection and reconstruction with and without rigid prosthesis. Annals of Thorcic Surgery 2006; 81: 279-285.

Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer Journal for Clincians 2006; 56: 143-159; quiz 184-185.

Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK; US Multi-society task force on colorectal cancer; American Cancer Society. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US multi-society task force on colorectal cancer and the American Cancer Society. Gastroenterology 2006; 130: 1872-1885.

Yoon SS, Kim SH, Gonen M, Heffernan NM, Detwiller KY, Jarnagin WR, D'Angelica M, Blumgart LH, Tanabe KK, Dematteo RP. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Annals of Surgical Oncology 2006; 13: 353-362.

Yossepowitch O, Eggener SE, Serio A, Huang WC, Snyder ME, Vickers AJ, Russo P. Temporary renal ischemia during nephron-sparing surgery is associated with short-term but not long-term impairment of renal function. Journal of Urology 2006; 176: 1339-1343.

Yuan J, Gallardo HF, Rasalan T, Ranganathan R, Wang J, Zhang Y, Panageas K, Stan R, Young JW, Houghton AN, Wolchok JD. In-vitro expansion of ag-specific t-cells by HLA-A*0201-transfected K562 cells for immune monitoring. Cytotherapy 2006; 8: 498-508.

Yuan J, Latouche JB, Hodges J, Houghton AN, Heller G, Sadelain M, Riviere I, Young JW. Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner. Journal of Immunology 2006; 176: 2357-2365.

Zakrzewski JL, Kochman AA, Lu SX, Terwey TH, Kim TD, Hubbard VM, Muriglan SJ, Suh D, Smith OM, Grubin J, Patel N, Chow A, Cabrera-Perez J, Radhakrishnan R, Diab A, Perales MA, Rizzuto G, Menet E, Pamer EG, Heller G, Zuniga-Pflucker JC, Alpdogan O, van den Brink MR. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nature Medicine 2006; 12: 1039-1047.

Zauber AG, Vogelaar I, van Ballegooijen M, Boer R, Schrag D, Habbema D, Winawer SJ. Impact of initial polypectomy versus follow-up surveillance colonoscopy on colorectal cancer in post-polypectomy patients. Gastroenterology 2006; 130: SA: 186: S1249

Zauber AG, Winawer SJ. High-quality colonoscopies must be an integral part of screening and surveillance programs. Gastroenterology 2006; 130: 620-621; author reply 621-622.

Zelefsky MJ, Ben-Porat L, Chan HM, Fearn PA, Venkatraman ES. Evaluation of postradiotherapy PSA patterns and correlation with 10-year disease free survival outcomes for prostate cancer. International Journal of Radiation Oncology, Biology, Physics 2006; 66: 382-388.

Zhao B, Schwartz LH, Moskowitz CS, Ginsberg MS, Rizvi NA, Kris MG. Lung cancer: computerized quantification of tumor response--initial results. Radiology 2006; 241: 892-898.